Global Meningococcal Vaccines Market Expected to Grow at a CAGR of 9.2% During 2018-2028

Albany, NY -- (SBWIRE) -- 10/18/2018 -- The meningococcal vaccines market is expected to be greatly influenced by increasing partnerships between public institutions and the private sector, which has been primary agenda behind public health initiatives worldwide. Over the past couple of years, the private-public partnerships have increased, which specifically focus on the provision of vaccines in developing nations.